Caesary Andita Gustria, Handayani Nina, Sujuti Hidayat
Department of Ophthalmology, Faculty of Medicine, Universitas Brawijaya, Dr. Saiful Anwar General Hospital, Malang 65111, Indonesia.
Int J Ophthalmol. 2023 Mar 18;16(3):342-347. doi: 10.18240/ijo.2023.03.02. eCollection 2023.
To evaluate the effect of epigallocatechin gallate (EGCG) in preventing lens opacity and the aggregation of lens αB-crystallin in model rats of diabetes mellitus (DM).
This experimental study included Wistar rats for DM as models and divided into 5 groups. The treatment groups were administered EGCG by orally for 20d and were then assessed for their degree of lens opacity with binocular microscope and lens αB-crystallin expression from Western blot analyze.
Pearson correlation test and regression analysis on EGCG exposure and final random blood sugar (RBS) obtained a significance level of <0.05. EGCG exposure can significantly lower RBS with an of 0.5634 (56.34%). The same analysis on EGCG exposure and the degree of lens opacity obtained a significance level of <0.05 and increased exposure to EGCG can significantly lower the degree of lens opacity with an of 0.8577 (85.77%). Correlation analysis between EGCG and the expression of lens αB-crystallin can be concluded that the higher the EGCG exposure administered, the higher the native lens αB-crystallin expression and the lower the aggregate lens αB-crystallin expression. There was also significant effect in which every 1 mg/kg body weight dose of EGCG can increase the native lens αB-crystallin expression by 0.0063 and decrease the aggregate lens αB-crystallin expression by 0.0076.
The administration of EGCG at a dose of 300, 600, and 1200 mg shows a significant effect on preventing lens opacity and aggregation of αB-crystallin in diabetic rat models and this research could be a biomolecular prevention of cataract.
评估表没食子儿茶素没食子酸酯(EGCG)对糖尿病(DM)模型大鼠晶状体混浊及晶状体αB-晶状体蛋白聚集的预防作用。
本实验研究以Wistar大鼠作为DM模型,分为5组。治疗组口服EGCG 20天,然后用双目显微镜评估晶状体混浊程度,并通过蛋白质印迹分析评估晶状体αB-晶状体蛋白表达。
对EGCG暴露量与最终随机血糖(RBS)进行Pearson相关性检验和回归分析,得到的显著性水平<0.05。EGCG暴露可显著降低RBS,效应值为0.5634(56.34%)。对EGCG暴露量与晶状体混浊程度进行同样分析,得到的显著性水平<0.05,增加EGCG暴露量可显著降低晶状体混浊程度,效应值为0.8577(85.77%)。EGCG与晶状体αB-晶状体蛋白表达的相关性分析可得出,EGCG暴露量越高,天然晶状体αB-晶状体蛋白表达越高,聚集的晶状体αB-晶状体蛋白表达越低。每1mg/kg体重剂量的EGCG可使天然晶状体αB-晶状体蛋白表达增加0.0063,使聚集的晶状体αB-晶状体蛋白表达降低0.0076,也有显著效果。
给予300、600和1200mg剂量的EGCG对糖尿病大鼠模型晶状体混浊及αB-晶状体蛋白聚集有显著预防作用,本研究可为白内障的生物分子预防提供依据。